Correlation Between CureVac NV and Invivyd
Can any of the company-specific risk be diversified away by investing in both CureVac NV and Invivyd at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CureVac NV and Invivyd into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CureVac NV and Invivyd, you can compare the effects of market volatilities on CureVac NV and Invivyd and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CureVac NV with a short position of Invivyd. Check out your portfolio center. Please also check ongoing floating volatility patterns of CureVac NV and Invivyd.
Diversification Opportunities for CureVac NV and Invivyd
-0.14 | Correlation Coefficient |
Good diversification
The 3 months correlation between CureVac and Invivyd is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding CureVac NV and Invivyd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Invivyd and CureVac NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CureVac NV are associated (or correlated) with Invivyd. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Invivyd has no effect on the direction of CureVac NV i.e., CureVac NV and Invivyd go up and down completely randomly.
Pair Corralation between CureVac NV and Invivyd
Given the investment horizon of 90 days CureVac NV is expected to generate 15.59 times less return on investment than Invivyd. But when comparing it to its historical volatility, CureVac NV is 6.11 times less risky than Invivyd. It trades about 0.04 of its potential returns per unit of risk. Invivyd is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 44.00 in Invivyd on December 20, 2024 and sell it today you would earn a total of 28.00 from holding Invivyd or generate 63.64% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
CureVac NV vs. Invivyd
Performance |
Timeline |
CureVac NV |
Invivyd |
CureVac NV and Invivyd Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with CureVac NV and Invivyd
The main advantage of trading using opposite CureVac NV and Invivyd positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CureVac NV position performs unexpectedly, Invivyd can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Invivyd will offset losses from the drop in Invivyd's long position.CureVac NV vs. Southern Home Medicl | CureVac NV vs. United Homes Group | CureVac NV vs. Webus International Limited | CureVac NV vs. FormFactor |
Invivyd vs. Recursion Pharmaceuticals | Invivyd vs. Atea Pharmaceuticals | Invivyd vs. Unity Biotechnology | Invivyd vs. Regenxbio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
CEOs Directory Screen CEOs from public companies around the world | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |